Medicare research priorities
This article was originally published in The Gray Sheet
Executive Summary
The Medicare Evidence Development and Coverage Advisory Committee will convene April 30 in Baltimore, Md., to discuss priorities for research topics important to the Medicare program. The meeting is a follow-up to MedCAC's Oct. 22 meeting on the issue (1"The Gray Sheet" Nov. 12, 2007, p. 8)
You may also be interested in...
In Need Of Evidence: Medicare Panel Prioritizes Research Efforts
Top research priorities for the elderly should include looking at carotid artery stenting, radiation therapy and prognostic markers for cancer, as well as a number of other areas applicable to devices and diagnostics, says the Medicare Evidence Development and Coverage Advisory Committee
Upgraded Paige Suite Gains CE-IVD and UKCA Marks
Paige’s AI has obtained CE-IVD and UKCA marks, allowing the launch of a breakthrough product that can spot biomarkers from images.
Sanofi Scores In Second-Line Myeloma But Still In Darzalex’s Shadow
The French company believes it has the best-in-class CD38 antibody with new PFS data, but Johnson & Johnson and Genmab’s Darzalex looks set to retain its advantage in multiple myeloma.